CNBX PHARMACEUTICALS INC. Payments to Acquire Equity Method Investments
CNBX PHARMACEUTICALS INC. (CNBX) reported Payments to Acquire Equity Method Investments of $1.92 million for the 6-month period ending 2019-02-28, per its 10-Q filed 2019-04-15.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireEquityMethodInvestments · last filed 2019-04-15
- CNBX PHARMACEUTICALS INC. payments to acquire equity method investments for the quarter ending 2019-02-28 was $700.00K.
- CNBX PHARMACEUTICALS INC. payments to acquire equity method investments for the quarter ending 2018-11-30 was $1.22M.
- CNBX PHARMACEUTICALS INC. payments to acquire equity method investments for the quarter ending 2018-02-28 was $0.00.
- CNBX PHARMACEUTICALS INC. payments to acquire equity method investments for the quarter ending 2017-11-30 was $0.00.
| Period end | Payments to Acquire Equity Method Investments 3 month | Payments to Acquire Equity Method Investments 6 month |
|---|---|---|
| 2019-02-28 | $700.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-04-15 | $1.92M 10-Q · filed 2019-04-15 |
| 2018-11-30 | $1.22M 10-Q · filed 2019-01-17 | |
| 2018-02-28 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-04-15 | $0.00 10-Q · filed 2019-04-15 |
| 2017-11-30 | $0.00 10-Q · filed 2019-01-17 |